A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a aggressive brain tumor known for its fast growth and insensitivity to standard treatments. Research are constantly underway to identify new management strategies, and recently, a novel biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is abundantly produced in GBM cells